Frontiers in Pharmacology (Aug 2023)
Corrigendum: Induction of RIPK3/MLKL-mediated necroptosis by Erigeron breviscapus injection exhibits potent antitumor effect
- Xiuping Guo,
- Rui Li,
- Jinjin Cui,
- Chujuan Hu,
- Haoyang Yu,
- Ling Ren,
- Yangyang Cheng,
- Jiandong Jiang,
- Xiao Ding,
- Lulu Wang
Affiliations
- Xiuping Guo
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Rui Li
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Jinjin Cui
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Chujuan Hu
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Haoyang Yu
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Ling Ren
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Yangyang Cheng
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Jiandong Jiang
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- Xiao Ding
- State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China
- Lulu Wang
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
- DOI
- https://doi.org/10.3389/fphar.2023.1271953
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
- Erigeron breviscapus injection
- Dengzhanxixin
- Erigeron breviscapus (Vant.) Hand.-Mazz
- colorectal cancer
- necroptosis
- drug resistance